Chinese herbal medicines for adverse events of transarterial chemoembolization in patients with primary liver cancer

This review has been withdrawn.

The reason for withdrawal and previous versions are archived and accessible within the withdrawn record in the Cochrane Library.

Health topics:

Cancer > Liver

Published:

9 November 2020

Authors:

Li X-Q, Zhou Q, Liu JP, Tao K-M, Chen H, Ling C

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Li X-Q, Zhou Q, Liu JP, Tao K-M, Chen H, Ling C. Chinese herbal medicines for adverse events of transarterial chemoembolization in patients with primary liver cancer (Protocol). Cochrane Database of Systematic Reviews 2020, Issue 11. Art. No.: CD010065. DOI: 10.1002/14651858.CD010065.pub2.